Uncategorized
Baseline characteristics help predict visual acuity outcomes after anti-VEGF treatment for wet AMD
Lower best corrected visual acuity, younger age and smaller total area of choroidal neovascularization at baseline may be significant predictors for visual acuity outcomes when treating wet age-related macular degeneration patients with ranibizumab, according to an analysis.The retrospective analysis of the phase 3 HARBOR study evaluated demographic and baseline characteristics that may predict visual acuity outcomes in patients with subfoveal wet AMD.